Abbott India Ltd
Abbott India Ltd (ABBOTINDIA) last reported results for the quarter ended Jun 2026, with sales of ₹1,814 crore and net profit of ₹429 crore. The stock last traded at ₹26,000, a market capitalisation of ₹55,143 crore, on a P/E of 34.2. Over the past 52 weeks the stock has ranged between ₹25,135 and ₹30,655. Figures are as of 9 Oct 2026 and are not real time.
Abbott India Ltd share price and key metrics
- Current price
- ₹26,000
- Market cap
- ₹55,143 cr
- Stock P/E
- 34.2
- Book value
- ₹2,247
- ROE
- 34.4%
- ROCE
- 44.8%
- Dividend yield
- 2.02%
- 52w high / low
- 30655/25135
Metrics as of 9 Oct 2026. Not real time.
Track Abbott India Ltd
Cruxal reads every Abbott India Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Abbott India Ltd growth and returns
- 10 Years
- 10%
- 5 Years
- 10%
- 3 Years
- 9%
- TTM
- 6%
- 10 Years
- 20%
- 5 Years
- 17%
- 3 Years
- 18%
- TTM
- 11%
- 10 Years
- 19%
- 5 Years
- 4%
- 3 Years
- 5%
- 1 Year
- -12%
- 10 Years
- 31%
- 5 Years
- 34%
- 3 Years
- 35%
- Last Year
- 34%
Abbott India Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹1,814 cr, up 4.4% from ₹1,738 cr a year earlier. Net profit was ₹429 cr, up 17.2% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,633 | 1,614 | 1,605 | 1,738 | 1,757 | 1,724 | 1,710 | 1,814 |
| Expenses | 1,194 | 1,178 | 1,176 | 1,293 | 1,255 | 1,261 | 1,229 | 1,291 |
| Operating profit | 439 | 436 | 429 | 446 | 502 | 463 | 481 | 522 |
| OPM % | 27% | 27% | 27% | 26% | 29% | 27% | 28% | 29% |
| Other income | 60 | 72 | 76 | 73 | 70 | 70 | 76 | 75 |
| Interest | 2 | 2 | 4 | 6 | 8 | 5 | 6 | 6 |
| Depreciation | 18 | 18 | 18 | 19 | 19 | 19 | 19 | 20 |
| Profit before tax | 479 | 488 | 483 | 493 | 546 | 509 | 531 | 572 |
| Tax % | 25% | 26% | 24% | 26% | 24% | 26% | 26% | 25% |
| Net profit | 359 | 361 | 367 | 366 | 415 | 376 | 395 | 429 |
| EPS (₹) | 168.76 | 169.78 | 172.73 | 172.18 | 195.43 | 176.93 | 185.86 | 201.66 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Abbott India Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,903 | 3,298 | 3,679 | 4,093 | 4,310 | 4,919 | 5,349 | 5,849 | 6,409 | 6,929 | 7,004 |
| Operating profit | 398 | 525 | 605 | 757 | 922 | 1,088 | 1,206 | 1,453 | 1,695 | 1,892 | 1,969 |
| OPM % | 14% | 16% | 16% | 18% | 21% | 22% | 23% | 25% | 26% | 27% | 28% |
| Net profit | 277 | 401 | 450 | 593 | 691 | 799 | 949 | 1,201 | 1,414 | 1,552 | 1,615 |
| EPS (₹) | 130.19 | 188.82 | 211.93 | 279.04 | 325.04 | 375.87 | 446.80 | 565.30 | 665.64 | 730.39 | 759.88 |
TTM is the trailing twelve months to the most recent quarter.
Abbott India Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves | 1,366 | 1,672 | 1,987 | 2,410 | 2,581 | 2,799 | 3,167 | 3,678 | 4,212 | 4,753 |
| Borrowings | 0 | 0 | 0 | 175 | 153 | 152 | 113 | 83 | 197 | 172 |
| Other liabilities | 679 | 723 | 932 | 940 | 1,086 | 1,253 | 1,254 | 1,411 | 1,487 | 1,556 |
| Total liabilities | 2,066 | 2,416 | 2,941 | 3,547 | 3,840 | 4,224 | 4,556 | 5,193 | 5,917 | 6,502 |
| Fixed assets | 110 | 81 | 105 | 270 | 251 | 271 | 237 | 225 | 336 | 331 |
| CWIP | 6 | 2 | 1 | 2 | 1 | 1 | 4 | 10 | 18 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other assets | 1,950 | 2,333 | 2,835 | 3,275 | 3,589 | 3,952 | 4,315 | 4,958 | 5,563 | 6,165 |
| Total assets | 2,066 | 2,416 | 2,941 | 3,547 | 3,840 | 4,224 | 4,556 | 5,193 | 5,917 | 6,502 |
As reported by the company. Total assets equal total liabilities by construction.
Abbott India Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 307 | 153 | 499 | 626 | 727 | 948 | 893 | 1,213 | 1,012 | 1,319 |
| Cash from investing | -155 | -215 | -257 | -401 | -72 | -396 | -148 | -416 | 182 | -371 |
| Cash from financing | -90 | -102 | -143 | -217 | -582 | -637 | -639 | -745 | -925 | -1,066 |
| Net cash flow | 62 | -165 | 99 | 8 | 73 | -86 | 107 | 52 | 269 | -118 |
| Free cash flow | 287 | 180 | 504 | 611 | 704 | 904 | 860 | 1,165 | 960 | 1,307 |
| CFO / operating profit | 117% | 68% | 125% | 113% | 104% | 114% | 102% | 111% | 86% | 98% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Abbott India Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 34% | 41% | 37% | 35% | 35% | 38% | 41% | 46% | 46% | 45% |
| Debtor days | 22 | 29 | 27 | 28 | 21 | 21 | 22 | 20 | 22 | 19 |
| Inventory days | 107 | 112 | 106 | 83 | 110 | 94 | 80 | 70 | 92 | 94 |
| Days payable | 101 | 92 | 116 | 104 | 116 | 122 | 109 | 114 | 110 | 109 |
| Cash conversion cycle | 28 | 49 | 17 | 8 | 14 | -6 | -8 | -24 | 3 | 3 |
| Working capital days | 21 | 63 | 22 | 10 | 4 | -7 | -8 | -14 | 99 | 2 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Abbott India Ltd shareholding pattern
Promoters held 74.99% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.38% and DIIs 8.77%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% |
| FIIs | 0.17% | 0.17% | 0.16% | 0.16% | 0.16% | 0.19% | 0.27% | 0.38% |
| DIIs | 9.00% | 9.01% | 8.91% | 9.18% | 9.11% | 9.00% | 8.93% | 8.77% |
| Public | 15.86% | 15.85% | 15.94% | 15.67% | 15.74% | 15.83% | 15.81% | 15.85% |
| No. of shareholders | 69,449 | 67,892 | 69,934 | 67,584 | 71,199 | 75,801 | 75,866 | 78,320 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Abbott India Ltd corporate filings
- Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.Company Updatelow impact
- Abbott India Ltd announces newspaper advertisement for special window on transfer and dematerialization of physical securitiesCompany Updatelow impact
Cruxal's analysis: On October 2, 2026, Abbott India Ltd disclosed a newspaper publication regarding a new…
Read the full analysis - Closure of Trading Window for declaration of Unaudited Financial Results of the Company for the quarter ending September 30, 2026.Insider Trading / SASTlow impact
- Abbott India Limited announces resignation of Company Secretary and Compliance OfficerCompany Updatelow impact
Cruxal's analysis: Abbott India Limited has informed the stock exchanges that Ms. Sangeeta Shetty, the…
Read the full analysis - Abbott India Limited concludes 82nd AGM; shareholders approve final and special dividend totaling 656 INR per shareAGM/EGMlow impact
Cruxal's analysis: Abbott India Limited has successfully concluded its 82nd Annual General Meeting held on…
Read the full analysis - Abbott India Ltd: Newspaper publication of financial resultsCompany Updatelow impact
Cruxal's analysis: Abbott India Ltd has fulfilled its regulatory obligation under Regulation 30 of the SEBI…
Read the full analysis - Abbott India Limited concludes 82nd AGM; declares total dividend of 656 INR per shareAGM/EGMlow impact
Cruxal's analysis: Abbott India Limited successfully concluded its 82nd Annual General Meeting on August 13…
Read the full analysis - Abbott India Q1 FY27 Results: Revenue at 1,813.68 crore and EPS at 201.66, reflecting steady growthResulthigh impact
Cruxal's analysis: Abbott India Limited reported a solid performance for the quarter ended June 30, 2026…
Read the full analysis - Abbott India Q1 FY27 Results: Revenue of 1,813.68 crore and EPS of 201.66 reflect steady growth; Board appoints new ChairmanBoard Meetinghigh impact
Cruxal's analysis: Abbott India Limited reported Q1 FY27 revenue from operations of 1,813.68 crore, marking…
Read the full analysis - Abbott India to Convene Board Meeting on August 12, 2026, to Approve Q1 FY27 Unaudited Financial ResultsBoard Meetinglow impact
Cruxal's analysis: Abbott India Limited has announced that its Board of Directors will convene a meeting on…
Read the full analysis - Abbott India publishes newspaper advertisement for dematerialization of physical securitiesCompany Updatelow impact
Cruxal's analysis: Abbott India Ltd. announced on 2026-08-04 the publication of a newspaper advertisement…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.